Page last updated: 2024-11-10

arachidonyltrifluoromethane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

arachidonyltrifluoromethane: structure given in first source; inhibits 85-kDa phospholipase A2 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

AACOCF3 : A fatty acid derivative that is arachidonic acid in which the OH part of the carboxy group has been replaced by a trifluoromethyl group [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5280436
CHEMBL ID281211
CHEBI ID2341
SCHEMBL ID9880640
MeSH IDM0217524

Synonyms (42)

Synonym
(6z,9z,12z,15z)-1,1,1-trifluorohenicosa-6,9,12,15-tetraen-2-one
CHEBI:2341 ,
arachidonic acid trifluoromethyl ketone
arachidonyl trifluoromethyl ketone
aacocf3
arachidonyltrifluoromethane
149301-79-1
C01397
arachidonyl trifluoromethylketone
6,9,12,15-heneicosatetraen-2-one, 1,1,1-trifluoro-, (6z,9z,12z,15z)-
atfmk
NCGC00162420-01
arachidonyltrifluoromethyl ketone
1,1,1-trifluoro-6z,9z,12z,15z-heneicosatetraen-2-one
6,9,12,15-heneicosatetraen-2-one, 1,1,1-trifluoro-, (all-z)-
c21h31f3o
an-20579 ,
l-734575
bm-162353
CHEMBL281211 ,
arachidonyltrifluoromethylketone
bdbm50059523
00xiw1cr0f ,
unii-00xiw1cr0f
BRD-K07303502-001-01-7
gtpl5142
arachidonoyltrifluoromethylketone
1,1,1-trifluoro-6z,9z,12z,15z-heneicosateraen-2-one
SCHEMBL9880640
1,1,1-trifluoro-6z,9z,12z,15z-henei cosateraen-2-one
HB2354
AKOS024456613
HMS3649A19
J-008577
Q25101107
sr-01000946553
SR-01000946553-1
(6z,9z,12z,15z)-1,1,1-trifluoro-6,9,12,15-heneicosatetraen-2-one
DTXSID901017144
HY-108611
6,9,12,15-heneicosatetraen-2-one,1,1,1-trifluoro-,(6z,9z,12z,15z)-
CS-0029314

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The data demonstrate that IL-4 up-regulates the expression of MCP-1 and decreases NO bioavailability through activation of NADPH oxidase in endothelial cells."( Pro-atherogenic effect of interleukin-4 in endothelial cells: modulation of oxidative stress, nitric oxide and monocyte chemoattractant protein-1 expression.
Brunet, A; Dufilho, M; Massade, L; Rendu, F; Walch, L, 2006
)
0.33

Dosage Studied

ExcerptRelevanceReference
" Our data suggested that PMA stimulated the production of superoxide anion in a dose-response manner, as compared with A23187, which did not induce a significant release of superoxide anion in PMNs-RA."( Phospholipase A2 modulates respiratory burst developed by neutrophils in patients with rheumatoid arthritis.
Bostan, M; Brasoveanu, LI; Constantin, MC; Galatiuc, C; Hirt, M; Iordachescu, D,
)
0.13
" The dose-response study of AA and IDM demonstrated that the concentration of intracellular AA accumulated by IDM is less than 100 nm."( Enhancement of Ca2+-regulated exocytosis by indomethacin in guinea-pig antral mucous cells: arachidonic acid accumulation.
Fujiwara, S; Kato, M; Katsu, K; Nakahari, T; Nakanishi, Y; Shimamoto, C, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
EC 3.1.1.4 (phospholipase A2) inhibitorAn EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of phospholipase A2 (EC 3.1.1.4).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
organofluorine compoundAn organofluorine compound is a compound containing at least one carbon-fluorine bond.
ketoneA compound in which a carbonyl group is bonded to two carbon atoms: R2C=O (neither R may be H).
olefinic compoundAny organic molecular entity that contains at least one C=C bond.
fatty acid derivativeAny organic molecular entity derived from a fatty acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (24)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Ferritin light chainEquus caballus (horse)Potency15.84895.623417.292931.6228AID485281
phosphopantetheinyl transferaseBacillus subtilisPotency28.18380.141337.9142100.0000AID1490
Microtubule-associated protein tauHomo sapiens (human)Potency29.88160.180013.557439.8107AID1460; AID1468
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency19.95260.011212.4002100.0000AID1030
Bloom syndrome protein isoform 1Homo sapiens (human)Potency25.11890.540617.639296.1227AID2528
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency28.18380.354828.065989.1251AID504847
DNA polymerase kappa isoform 1Homo sapiens (human)Potency28.18380.031622.3146100.0000AID588579
Polyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)Potency19.95260.316212.765731.6228AID881
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency19.95260.00638.235039.8107AID881
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Fatty-acid amide hydrolase 1Homo sapiens (human)IC50 (µMol)1.00820.00020.59827.0000AID241677; AID439742; AID441698
Neuronal acetylcholine receptor subunit alpha-4Rattus norvegicus (Norway rat)IC50 (µMol)2.30000.00030.30952.3000AID460727
Cytosolic phospholipase A2 betaHomo sapiens (human)IC50 (µMol)0.80000.80000.80000.8000AID158952
Neuronal acetylcholine receptor subunit beta-2Rattus norvegicus (Norway rat)IC50 (µMol)2.30000.00030.32092.3000AID460727
Cytosolic phospholipase A2Homo sapiens (human)IC50 (µMol)2.30000.00051.09862.3000AID294593; AID327583; AID460727
Fatty-acid amide hydrolase 1Rattus norvegicus (Norway rat)IC50 (µMol)3.70000.00051.33138.0000AID460725
Platelet-activating factor acetylhydrolaseHomo sapiens (human)IC50 (µMol)0.80000.00000.38373.9000AID158952
Monoglyceride lipaseHomo sapiens (human)IC50 (µMol)6.38330.00091.126810.0000AID439741; AID441697
Cytosolic phospholipase A2 gammaHomo sapiens (human)IC50 (µMol)0.42000.42000.42000.4200AID55271
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Glutamate receptor 1Rattus norvegicus (Norway rat)EC50 (µMol)25.11890.00411.89638.7000AID257800
Glutamate receptor 2Rattus norvegicus (Norway rat)EC50 (µMol)25.11890.00411.62517.6000AID257800
Glutamate receptor 3Rattus norvegicus (Norway rat)EC50 (µMol)25.11890.00411.17063.5000AID257800
Glutamate receptor 4Rattus norvegicus (Norway rat)EC50 (µMol)25.11890.00411.13393.5000AID257800
Cannabinoid receptor 1Rattus norvegicus (Norway rat)EC50 (µMol)25.11890.00020.19211.9953AID257800
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (63)

Processvia Protein(s)Taxonomy
prostaglandin biosynthetic processCytosolic phospholipase A2 Bos taurus (cattle)
glycerol metabolic processCytosolic phospholipase A2 Bos taurus (cattle)
monoacylglycerol biosynthetic processCytosolic phospholipase A2 Bos taurus (cattle)
positive regulation of platelet activationCytosolic phospholipase A2 Bos taurus (cattle)
arachidonic acid metabolic processCytosolic phospholipase A2 Bos taurus (cattle)
leukotriene biosynthetic processCytosolic phospholipase A2 Bos taurus (cattle)
phosphatidylglycerol catabolic processCytosolic phospholipase A2 Bos taurus (cattle)
phosphatidylcholine catabolic processCytosolic phospholipase A2 Bos taurus (cattle)
phosphatidylcholine acyl-chain remodelingCytosolic phospholipase A2 Bos taurus (cattle)
fatty acid catabolic processFatty-acid amide hydrolase 1Homo sapiens (human)
arachidonic acid metabolic processFatty-acid amide hydrolase 1Homo sapiens (human)
positive regulation of vasoconstrictionFatty-acid amide hydrolase 1Homo sapiens (human)
monoacylglycerol catabolic processFatty-acid amide hydrolase 1Homo sapiens (human)
lipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
phospholipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
apoptotic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell population proliferationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell migrationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
prostate gland developmentPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
regulation of epithelial cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of chemokine productionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of peroxisome proliferator activated receptor signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of keratinocyte differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell cyclePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of growthPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
hepoxilin biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
endocannabinoid signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cannabinoid biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxin A4 biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
inflammatory responseCytosolic phospholipase A2 betaHomo sapiens (human)
parturitionCytosolic phospholipase A2 betaHomo sapiens (human)
arachidonic acid metabolic processCytosolic phospholipase A2 betaHomo sapiens (human)
calcium-mediated signalingCytosolic phospholipase A2 betaHomo sapiens (human)
phosphatidylglycerol acyl-chain remodelingCytosolic phospholipase A2 betaHomo sapiens (human)
glycerophospholipid catabolic processCytosolic phospholipase A2 betaHomo sapiens (human)
prostaglandin biosynthetic processCytosolic phospholipase A2Homo sapiens (human)
positive regulation of T-helper 1 type immune responseCytosolic phospholipase A2Homo sapiens (human)
glycerol metabolic processCytosolic phospholipase A2Homo sapiens (human)
monoacylglycerol biosynthetic processCytosolic phospholipase A2Homo sapiens (human)
platelet activating factor biosynthetic processCytosolic phospholipase A2Homo sapiens (human)
icosanoid metabolic processCytosolic phospholipase A2Homo sapiens (human)
positive regulation of platelet activationCytosolic phospholipase A2Homo sapiens (human)
arachidonic acid metabolic processCytosolic phospholipase A2Homo sapiens (human)
leukotriene biosynthetic processCytosolic phospholipase A2Homo sapiens (human)
positive regulation of prostaglandin secretionCytosolic phospholipase A2Homo sapiens (human)
phosphatidylglycerol catabolic processCytosolic phospholipase A2Homo sapiens (human)
phosphatidylcholine catabolic processCytosolic phospholipase A2Homo sapiens (human)
phosphatidylcholine acyl-chain remodelingCytosolic phospholipase A2Homo sapiens (human)
regulation of cell population proliferationCytosolic phospholipase A2Homo sapiens (human)
positive regulation of macrophage activationCytosolic phospholipase A2Homo sapiens (human)
arachidonic acid secretionCytosolic phospholipase A2Homo sapiens (human)
establishment of localization in cellCytosolic phospholipase A2Homo sapiens (human)
cellular response to antibioticCytosolic phospholipase A2Homo sapiens (human)
glycerophospholipid catabolic processCytosolic phospholipase A2Homo sapiens (human)
peptide hormone processingPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
low-density lipoprotein particle remodelingPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
lipid oxidationPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
plasma lipoprotein particle oxidationPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
phosphatidylcholine catabolic processPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
platelet activating factor metabolic processPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
positive regulation of inflammatory responsePlatelet-activating factor acetylhydrolaseHomo sapiens (human)
platelet activating factor catabolic processPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
positive regulation of monocyte chemotaxisPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
lipid metabolic processMonoglyceride lipaseHomo sapiens (human)
fatty acid biosynthetic processMonoglyceride lipaseHomo sapiens (human)
inflammatory responseMonoglyceride lipaseHomo sapiens (human)
regulation of signal transductionMonoglyceride lipaseHomo sapiens (human)
arachidonic acid metabolic processMonoglyceride lipaseHomo sapiens (human)
triglyceride catabolic processMonoglyceride lipaseHomo sapiens (human)
acylglycerol catabolic processMonoglyceride lipaseHomo sapiens (human)
regulation of inflammatory responseMonoglyceride lipaseHomo sapiens (human)
regulation of sensory perception of painMonoglyceride lipaseHomo sapiens (human)
monoacylglycerol catabolic processMonoglyceride lipaseHomo sapiens (human)
regulation of endocannabinoid signaling pathwayMonoglyceride lipaseHomo sapiens (human)
phospholipid metabolic processCytosolic phospholipase A2 gammaHomo sapiens (human)
platelet activating factor biosynthetic processCytosolic phospholipase A2 gammaHomo sapiens (human)
inflammatory responseCytosolic phospholipase A2 gammaHomo sapiens (human)
parturitionCytosolic phospholipase A2 gammaHomo sapiens (human)
arachidonic acid metabolic processCytosolic phospholipase A2 gammaHomo sapiens (human)
intracellular signal transductionCytosolic phospholipase A2 gammaHomo sapiens (human)
phosphatidylcholine acyl-chain remodelingCytosolic phospholipase A2 gammaHomo sapiens (human)
phosphatidylethanolamine acyl-chain remodelingCytosolic phospholipase A2 gammaHomo sapiens (human)
glycerophospholipid catabolic processCytosolic phospholipase A2 gammaHomo sapiens (human)
lipid droplet formationCytosolic phospholipase A2 gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (28)

Processvia Protein(s)Taxonomy
lysophospholipase activityCytosolic phospholipase A2 Bos taurus (cattle)
phospholipase A2 activityCytosolic phospholipase A2 Bos taurus (cattle)
calcium ion bindingCytosolic phospholipase A2 Bos taurus (cattle)
calcium-dependent phospholipid bindingCytosolic phospholipase A2 Bos taurus (cattle)
O-acyltransferase activityCytosolic phospholipase A2 Bos taurus (cattle)
phosphatidylinositol-5-phosphate bindingCytosolic phospholipase A2 Bos taurus (cattle)
phosphatidylinositol-3-phosphate bindingCytosolic phospholipase A2 Bos taurus (cattle)
calcium-dependent phospholipase A2 activityCytosolic phospholipase A2 Bos taurus (cattle)
calcium-independent phospholipase A2 activityCytosolic phospholipase A2 Bos taurus (cattle)
phosphatidylinositol-4-phosphate bindingCytosolic phospholipase A2 Bos taurus (cattle)
phosphatidyl phospholipase B activityCytosolic phospholipase A2 Bos taurus (cattle)
ceramide 1-phosphate bindingCytosolic phospholipase A2 Bos taurus (cattle)
protein bindingFatty-acid amide hydrolase 1Homo sapiens (human)
phospholipid bindingFatty-acid amide hydrolase 1Homo sapiens (human)
fatty acid amide hydrolase activityFatty-acid amide hydrolase 1Homo sapiens (human)
identical protein bindingFatty-acid amide hydrolase 1Homo sapiens (human)
acylglycerol lipase activityFatty-acid amide hydrolase 1Homo sapiens (human)
amidase activityFatty-acid amide hydrolase 1Homo sapiens (human)
iron ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
calcium ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
protein bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 13S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 15-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 9S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lysophospholipase activityCytosolic phospholipase A2 betaHomo sapiens (human)
phospholipase A2 activityCytosolic phospholipase A2 betaHomo sapiens (human)
calcium ion bindingCytosolic phospholipase A2 betaHomo sapiens (human)
calcium-dependent phospholipid bindingCytosolic phospholipase A2 betaHomo sapiens (human)
phospholipase A1 activityCytosolic phospholipase A2 betaHomo sapiens (human)
calcium-dependent phospholipase A2 activityCytosolic phospholipase A2 betaHomo sapiens (human)
phosphatidyl phospholipase B activityCytosolic phospholipase A2 betaHomo sapiens (human)
lysophospholipase activityCytosolic phospholipase A2Homo sapiens (human)
phospholipase A2 activityCytosolic phospholipase A2Homo sapiens (human)
calcium ion bindingCytosolic phospholipase A2Homo sapiens (human)
calcium-dependent phospholipid bindingCytosolic phospholipase A2Homo sapiens (human)
O-acyltransferase activityCytosolic phospholipase A2Homo sapiens (human)
phosphatidylinositol-5-phosphate bindingCytosolic phospholipase A2Homo sapiens (human)
phosphatidylinositol-3-phosphate bindingCytosolic phospholipase A2Homo sapiens (human)
calcium-dependent phospholipase A2 activityCytosolic phospholipase A2Homo sapiens (human)
calcium-independent phospholipase A2 activityCytosolic phospholipase A2Homo sapiens (human)
phosphatidylinositol-4-phosphate bindingCytosolic phospholipase A2Homo sapiens (human)
phosphatidyl phospholipase B activityCytosolic phospholipase A2Homo sapiens (human)
ceramide 1-phosphate bindingCytosolic phospholipase A2Homo sapiens (human)
1-alkyl-2-acetylglycerophosphocholine esterase activityPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
phospholipid bindingPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
hydrolase activity, acting on ester bondsPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
calcium-independent phospholipase A2 activityPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
lysophospholipase activityMonoglyceride lipaseHomo sapiens (human)
protein bindingMonoglyceride lipaseHomo sapiens (human)
protein homodimerization activityMonoglyceride lipaseHomo sapiens (human)
acylglycerol lipase activityMonoglyceride lipaseHomo sapiens (human)
lysophospholipase activityCytosolic phospholipase A2 gammaHomo sapiens (human)
protein bindingCytosolic phospholipase A2 gammaHomo sapiens (human)
phospholipid bindingCytosolic phospholipase A2 gammaHomo sapiens (human)
O-acyltransferase activityCytosolic phospholipase A2 gammaHomo sapiens (human)
phospholipase A1 activityCytosolic phospholipase A2 gammaHomo sapiens (human)
calcium-independent phospholipase A2 activityCytosolic phospholipase A2 gammaHomo sapiens (human)
phosphatidyl phospholipase B activityCytosolic phospholipase A2 gammaHomo sapiens (human)
calcium ion bindingCytosolic phospholipase A2 gammaHomo sapiens (human)
calcium-dependent phospholipid bindingCytosolic phospholipase A2 gammaHomo sapiens (human)
calcium-dependent phospholipase A2 activityCytosolic phospholipase A2 gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (25)

Processvia Protein(s)Taxonomy
Golgi membraneCytosolic phospholipase A2 Bos taurus (cattle)
nuclear envelopeCytosolic phospholipase A2 Bos taurus (cattle)
cytoplasmCytosolic phospholipase A2 Bos taurus (cattle)
endoplasmic reticulum membraneFatty-acid amide hydrolase 1Homo sapiens (human)
cytoskeletonFatty-acid amide hydrolase 1Homo sapiens (human)
organelle membraneFatty-acid amide hydrolase 1Homo sapiens (human)
nucleusPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytosolPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytoskeletonPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
plasma membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
adherens junctionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
focal adhesionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular exosomePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular regionCytosolic phospholipase A2 betaHomo sapiens (human)
mitochondrial inner membraneCytosolic phospholipase A2 betaHomo sapiens (human)
cytosolCytosolic phospholipase A2 betaHomo sapiens (human)
early endosome membraneCytosolic phospholipase A2 betaHomo sapiens (human)
cytosolCytosolic phospholipase A2 betaHomo sapiens (human)
plasma membraneGlutamate receptor 1Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
Golgi membraneCytosolic phospholipase A2Homo sapiens (human)
nuclear envelopeCytosolic phospholipase A2Homo sapiens (human)
cytoplasmCytosolic phospholipase A2Homo sapiens (human)
mitochondrial inner membraneCytosolic phospholipase A2Homo sapiens (human)
endoplasmic reticulum membraneCytosolic phospholipase A2Homo sapiens (human)
cytosolCytosolic phospholipase A2Homo sapiens (human)
intracellular membrane-bounded organelleCytosolic phospholipase A2Homo sapiens (human)
nucleusCytosolic phospholipase A2Homo sapiens (human)
endoplasmic reticulumCytosolic phospholipase A2Homo sapiens (human)
Golgi apparatusCytosolic phospholipase A2Homo sapiens (human)
cytosolCytosolic phospholipase A2Homo sapiens (human)
extracellular regionPlatelet-activating factor acetylhydrolaseHomo sapiens (human)
low-density lipoprotein particlePlatelet-activating factor acetylhydrolaseHomo sapiens (human)
high-density lipoprotein particlePlatelet-activating factor acetylhydrolaseHomo sapiens (human)
endoplasmic reticulum membraneMonoglyceride lipaseHomo sapiens (human)
cytosolMonoglyceride lipaseHomo sapiens (human)
plasma membraneMonoglyceride lipaseHomo sapiens (human)
membraneMonoglyceride lipaseHomo sapiens (human)
membraneMonoglyceride lipaseHomo sapiens (human)
endoplasmic reticulum membraneCytosolic phospholipase A2 gammaHomo sapiens (human)
lipid dropletCytosolic phospholipase A2 gammaHomo sapiens (human)
cytosolCytosolic phospholipase A2 gammaHomo sapiens (human)
plasma membraneCytosolic phospholipase A2 gammaHomo sapiens (human)
cell cortexCytosolic phospholipase A2 gammaHomo sapiens (human)
membraneCytosolic phospholipase A2 gammaHomo sapiens (human)
mitochondrial membraneCytosolic phospholipase A2 gammaHomo sapiens (human)
nuclear envelopeCytosolic phospholipase A2 gammaHomo sapiens (human)
cytosolCytosolic phospholipase A2 gammaHomo sapiens (human)
nucleoplasmCytosolic phospholipase A2 gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (35)

Assay IDTitleYearJournalArticle
AID439741Inhibition of human MGL2009Journal of medicinal chemistry, Dec-10, Volume: 52, Issue:23
Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors.
AID460730inhibition of MAGL up to 10 uM2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A(2)alpha and fatty acid amide hydrolase.
AID209198Concentration required to inhibit production of arachidonic acid from THP-1 cells stimulated with A-231872001Bioorganic & medicinal chemistry letters, Feb-26, Volume: 11, Issue:4
Pyrrolidine inhibitors of human cytosolic phospholipase A2. Part 2: synthesis of potent and crystallized 4-triphenylmethylthio derivative 'pyrrophenone'.
AID460727Inhibition of cPLA2 from human platelets by RP-HPLC2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A(2)alpha and fatty acid amide hydrolase.
AID439742Inhibition of human FAAH2009Journal of medicinal chemistry, Dec-10, Volume: 52, Issue:23
Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors.
AID26961Calculated partition coefficient (clogP)2002Journal of medicinal chemistry, Mar-14, Volume: 45, Issue:6
Design and synthesis of a novel and potent series of inhibitors of cytosolic phospholipase A(2) based on a 1,3-disubstituted propan-2-one skeleton.
AID327585Metabolic stability in rat liver microsomes at 20 uM after 30 mins in presence of NADPH by reverse phased HPLC relative to control2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
1-(2-Carboxyindol-5-yloxy)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: synthesis, biological activity, metabolic stability, and solubility.
AID579237Inhibition of human platelet cytosolic phospholipase A2alpha2011Bioorganic & medicinal chemistry letters, Mar-15, Volume: 21, Issue:6
Structure-activity relationship studies on 1-(5-carboxyindol-1-yl)-propan-2-one inhibitors of human cytosolic phospholipase A2α: variation of the activated ketone moiety.
AID223077Concentration required to inhibit production of TXB2 from whole blood stimulated with A-231872001Bioorganic & medicinal chemistry letters, Feb-26, Volume: 11, Issue:4
Pyrrolidine inhibitors of human cytosolic phospholipase A2. Part 2: synthesis of potent and crystallized 4-triphenylmethylthio derivative 'pyrrophenone'.
AID42841The cell lytic potency at a compound concentration of 33 uM in bovine platelets was determined1997Journal of medicinal chemistry, Aug-15, Volume: 40, Issue:17
Synthesis, biological evaluation, and structure-activity relationships of 3-acylindole-2-carboxylic acids as inhibitors of the cytosolic phospholipase A2.
AID1336744Inhibition of human calcium-independent group-6A iPLA2 using Triton-X-100/DPPC containing 1-palmitoyl-2-[1-14C]palmitoyl-sn-glycero-3-phosphorylcholine substrate mixed micelles at 0.091 mole_fraction by modified dole assay relative to control2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
2-Oxoamides based on dipeptides as selective calcium-independent phospholipase A
AID223074Concentration required to inhibit production of LDH from whole blood stimulated with A-231872001Bioorganic & medicinal chemistry letters, Feb-26, Volume: 11, Issue:4
Pyrrolidine inhibitors of human cytosolic phospholipase A2. Part 2: synthesis of potent and crystallized 4-triphenylmethylthio derivative 'pyrrophenone'.
AID294593Inhibition of human platelet cPLA2-alpha assessed as arachidonic acid release by vesicle assay2007Bioorganic & medicinal chemistry, Apr-15, Volume: 15, Issue:8
1-(5-Carboxy- and 5-carbamoylindol-1-yl)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: bioisosteric replacement of the carboxylic acid and carboxamide moiety.
AID441697Inhibition of human MGL activity using [3H]2-oleoylglycerol substrate by liquid scintillation counting2009Journal of medicinal chemistry, Nov-26, Volume: 52, Issue:22
Bis(dialkylaminethiocarbonyl)disulfides as potent and selective monoglyceride lipase inhibitors.
AID1632259Inhibition of human group 4A cPLA2 using [14C]-labeled PAPC as substrate after 30 mins by mixed micelle assay based liquid scintillation counting2016Bioorganic & medicinal chemistry, 10-01, Volume: 24, Issue:19
2-Oxoamide inhibitors of cytosolic group IVA phospholipase A2 with reduced lipophilicity.
AID223076Concentration required to inhibit production of PGE-2 from whole blood stimulated with A-231872001Bioorganic & medicinal chemistry letters, Feb-26, Volume: 11, Issue:4
Pyrrolidine inhibitors of human cytosolic phospholipase A2. Part 2: synthesis of potent and crystallized 4-triphenylmethylthio derivative 'pyrrophenone'.
AID257800Displacement of [35S]GTP-gamma-S from rat cerebellar CB1 receptor2006Journal of medicinal chemistry, Jan-26, Volume: 49, Issue:2
3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data.
AID441698Inhibition of human recombinant FAAH-maltose binding protein2009Journal of medicinal chemistry, Nov-26, Volume: 52, Issue:22
Bis(dialkylaminethiocarbonyl)disulfides as potent and selective monoglyceride lipase inhibitors.
AID441792Selectivity ratio for human MGL activity to human recombinant FAAH2009Journal of medicinal chemistry, Nov-26, Volume: 52, Issue:22
Bis(dialkylaminethiocarbonyl)disulfides as potent and selective monoglyceride lipase inhibitors.
AID327583Inhibition of human platelet cPLA2-alpha activity2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
1-(2-Carboxyindol-5-yloxy)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: synthesis, biological activity, metabolic stability, and solubility.
AID82983Inhibition of [3H]arachidonic acid production by stimulated HL60 cells.2002Journal of medicinal chemistry, Mar-14, Volume: 45, Issue:6
Design and synthesis of a novel and potent series of inhibitors of cytosolic phospholipase A(2) based on a 1,3-disubstituted propan-2-one skeleton.
AID209196Concentration required to inhibit production of LTC4 from THP-1 cells stimulated with A-231872001Bioorganic & medicinal chemistry letters, Feb-26, Volume: 11, Issue:4
Pyrrolidine inhibitors of human cytosolic phospholipase A2. Part 2: synthesis of potent and crystallized 4-triphenylmethylthio derivative 'pyrrophenone'.
AID55261Inhibition of cPLA2 measuring Calcium ionophore A-23,187-induced arachidonic acid release from bovine platelets with HPLC/UV detection.1997Journal of medicinal chemistry, Oct-10, Volume: 40, Issue:21
Structure-activity relationships of (4-acylpyrrol-2-yl)alkanoic acids as inhibitors of the cytosolic phospholipase A2: variation of the substituents in positions 1, 3, and 5.
AID460725Inhibition of FAAH from rat brain microsomes by RP-HPLC2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A(2)alpha and fatty acid amide hydrolase.
AID55271Concentration required to inhibit human Cytosolic phospholipase A22001Bioorganic & medicinal chemistry letters, Feb-26, Volume: 11, Issue:4
Pyrrolidine inhibitors of human cytosolic phospholipase A2. Part 2: synthesis of potent and crystallized 4-triphenylmethylthio derivative 'pyrrophenone'.
AID223078Concentration required to inhibit production of arachidonic acid from whole blood stimulated with A-231872001Bioorganic & medicinal chemistry letters, Feb-26, Volume: 11, Issue:4
Pyrrolidine inhibitors of human cytosolic phospholipase A2. Part 2: synthesis of potent and crystallized 4-triphenylmethylthio derivative 'pyrrophenone'.
AID241677Inhibition of fatty acid amide hydrolase; range =. 23-3 uM2005Journal of medicinal chemistry, Aug-11, Volume: 48, Issue:16
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.
AID158783Inhibitory activity against cPLA2 (cytosolic Phospholipase A2) by measuring the calcium ionophore A-23,187-induced arachidonic acid release from bovine platelets1997Journal of medicinal chemistry, Aug-15, Volume: 40, Issue:17
Synthesis, biological evaluation, and structure-activity relationships of 3-acylindole-2-carboxylic acids as inhibitors of the cytosolic phospholipase A2.
AID439743Selectivity ratio of IC50 for human FAAH to IC50 for human MGL2009Journal of medicinal chemistry, Dec-10, Volume: 52, Issue:23
Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors.
AID439753Inhibition of [3H]2-OG binding to human MGL at 20 times IC50 treated for 1 hr before addition of 2-OG by liquid scintillation counting2009Journal of medicinal chemistry, Dec-10, Volume: 52, Issue:23
Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors.
AID158952Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assay2002Journal of medicinal chemistry, Mar-14, Volume: 45, Issue:6
Design and synthesis of a novel and potent series of inhibitors of cytosolic phospholipase A(2) based on a 1,3-disubstituted propan-2-one skeleton.
AID223075Concentration required to inhibit production of LTB4 from whole blood stimulated with A-231872001Bioorganic & medicinal chemistry letters, Feb-26, Volume: 11, Issue:4
Pyrrolidine inhibitors of human cytosolic phospholipase A2. Part 2: synthesis of potent and crystallized 4-triphenylmethylthio derivative 'pyrrophenone'.
AID1336745Inhibition of human group-4 cPLA2 using Triton-X-100/DPPC containing 1-palmitoyl-2-[1-14C]palmitoyl-sn-glycero-3-phosphorylcholine substrate mixed micelles at 0.091 mole_fraction by modified dole assay relative to control2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
2-Oxoamides based on dipeptides as selective calcium-independent phospholipase A
AID159921Percentage platelet cell lysis at 33 uM measured by turbidimetry.1997Journal of medicinal chemistry, Oct-10, Volume: 40, Issue:21
Structure-activity relationships of (4-acylpyrrol-2-yl)alkanoic acids as inhibitors of the cytosolic phospholipase A2: variation of the substituents in positions 1, 3, and 5.
AID327586Solubility in sodium phosphate buffer at pH 7.42008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
1-(2-Carboxyindol-5-yloxy)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: synthesis, biological activity, metabolic stability, and solubility.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (230)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's66 (28.70)18.2507
2000's123 (53.48)29.6817
2010's38 (16.52)24.3611
2020's3 (1.30)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 8.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index8.91 (24.57)
Research Supply Index5.49 (2.92)
Research Growth Index4.40 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (8.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.42%)5.53%
Reviews2 (0.83%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other237 (98.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]